good point; going by the last presentation, between the lines, we’re on track for a bumper result FY 2022-23. The expected lift in dividend should reflect in the sp in due course along with the underlying trend.
- Forums
- ASX - By Stock
- News: CSL Csl Behring Receives FDA Approval For Hizentra® (Immune Globulin Subcutaneous <Origin...
CSL
csl limited
Add to My Watchlist
3.67%
!
$264.69

good point; going by the last presentation, between the lines,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$264.69 |
Change
9.380(3.67%) |
Mkt cap ! $127.6B |
Open | High | Low | Value | Volume |
$258.12 | $264.81 | $257.91 | $165.6M | 632.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $264.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$264.70 | 9 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 36 | 264.630 |
2 | 35 | 264.600 |
2 | 67 | 264.590 |
1 | 40 | 264.580 |
2 | 10 | 264.570 |
Price($) | Vol. | No. |
---|---|---|
264.680 | 58 | 7 |
264.690 | 50 | 5 |
264.700 | 9 | 1 |
264.710 | 268 | 6 |
264.720 | 42 | 2 |
Last trade - 14.10pm 22/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |